Trademark Overview
On Tuesday, March 17, 2026, a trademark application was filed for PARZYMIO with the United States Patent and Trademark Office. The USPTO has given the PARZYMIO trademark a serial number of 99707733. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 15, 2026. This trademark is owned by AstraZeneca AB. The PARZYMIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes